# A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women

> **NCT06453356** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zavegepant 10mg

## Key facts

- **NCT ID:** NCT06453356
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-10
- **Primary completion:** 2024-09-26
- **Final completion:** 2024-09-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06453356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06453356, "A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06453356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*